View ValuationeHealth 향후 성장Future 기준 점검 0/6eHealth 의 수익은 연간 5.7% 감소할 것으로 예상되는 반면, 연간 수익은 6.4% 로 증가할 것으로 예상됩니다. EPS는 연간 19.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -1.5% 로 예상됩니다.핵심 정보6.4%이익 성장률19.46%EPS 성장률Insurance 이익 성장1.5%매출 성장률-5.7%향후 자기자본이익률-1.46%애널리스트 커버리지Low마지막 업데이트14 May 2026최근 향후 성장 업데이트공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.공시 • May 08eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. reiterated earnings guidance for the full year ending December 31, 2024. For the year, the company total revenue is expected to be in the range of $450 million to $475 million and GAAP net loss is expected to be in the range of $40 million to $20 million.공시 • Feb 29eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, company expects Total revenue to be in the range of $450 million to $475 million and GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.공시 • Nov 10eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023eHealth, Inc. provided earnings guidance of the year ending December 31, 2023. For the period, the company expects total revenue to be in the range of $439 million to $459 million and GAAP net loss is expected to be in the range of $46 million to $26 million.모든 업데이트 보기Recent updatesNew Risk • Jul 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$22m net loss in 2 years). Market cap is less than US$100m (€47.5m market cap, or US$54.3m).공시 • Jun 29+ 10 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Value BenchmarkeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Value Benchmark공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2026eHealth, Inc., Annual General Meeting, Jun 18, 2026.공시 • Apr 23eHealth, Inc. to Report Q1, 2026 Results on May 06, 2026eHealth, Inc. announced that they will report Q1, 2026 results on May 06, 2026공시 • Apr 17eHealth Announces Final Expense Life Insurance PlanseHealth had announced it now offers Final Expense life insurance plans, helping Americans and their families prepare for funeral and burial or cremation expenses. The new plans are part of eHealth's strategy to better meet the coverage and wellness needs of individuals and families, offering an expanded portfolio of plans, services and support to help consumers live healthier, more financially secure lives. A new eHealth survey of over 1,000 Americans aged 65 and older found many people are unprepared to cover end-of-life expenses. Key survey findings include: 69% underestimate the average cost of a funeral with viewing and cremation, while 35% underestimate the average cost of a funeral with burial. 62% plan to be cremated, while 23% prefer to be buried; 15% don't know or have no preference. 47% worry about burdening loved ones with the cost of a funeral and burial or cremation. Among survey respondents living on an income of less than $50,000 per year: 56% worry about burdening their loved ones with the cost of a funeral and burial or cremation. 33% have no insurance or money set aside to help cover these end-of-life expenses. EHealth's Final Expense plans are offered through Mutual of Omaha and available by phone, allowing licensed insurance agents to address coverage options as part of a broader, personalized financial protection discussion. The policies can provide tax-free funds for various purposes, including funeral and burial or cremation expenses, outstanding medical bills, travel costs, legal fees, or other related needs. Two types of Final Expense plans are available: Level Benefit Plans, offered to people ages 45 to 85, with coverage amounts ranging from $2,000 to $50,000. Graded Benefit Plans, offered to people ages 45 to 80, with coverage amounts ranging from $2,000 to $20,000. Applicants are not required to undergo a medical exam to qualify for coverage. Instead, eligibility is determined through responses to a limited set of health questions covering a lookback period of approximately two to four years. The plans are designed to be affordable and provide beneficiaries with quick access to guaranteed funds, helping reduce financial stress during a difficult time. The average cost of a funeral with a viewing and burial exceeds $8,000, while the average cost of a funeral with a viewing and cremation is more than $6,000. Specific plan availability may vary by state; some plans may not be available in Arkansas, Montana, New York, and North Carolina. Coverage and premiums may vary based on qualifying factors.공시 • Apr 01Andrea Brimmer to Step Down from Board of Directors of eHealth, Inc. on June 18, 2026eHealth, Inc. announced that Andrea Brimmer will not stand for re-election to the Company's Board of Directors and will step down when her current term expires at the Company's next annual meeting of shareholders to be held on June 18, 2026. Ms. Brimmer will continue to serve as a member of the Board until the expiration of her term at the Company's upcoming annual meeting.공시 • Feb 10eHealth, Inc. to Report Q4, 2025 Results on Feb 25, 2026eHealth, Inc. announced that they will report Q4, 2025 results on Feb 25, 2026공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.공시 • Nov 12eHealth Advances its AI Strategy with Expanded Voice Agent CapabilitieseHealth announced the expanded use of Alice, its AI-powered voice agent. Alice has expanded beyond its initial use for shopping and initial enrollment telephone support and is now assisting with post-enrollment and general service calls from Medicare Advantage beneficiaries, helping to efficiently address and resolve common inquiries such as: Application status: Alice provides customers with general information on their application status as provided by the health plan. Soon, she will also be able to look up specific details and inform callers exactly where their application is with the health plan in the process. ID card inquiries: Alice informs customers when they generally can expect to receive their insurance ID cards and, if necessary, directs them to contact their health plan for further assistance. Billing questions: Alice provides customers with direct billing contact phone numbers for their respective health plan, making it easier for individuals to access assistance when billing support is required. Do Not Call requests: Alice can initiate steps to remove customers from eHealth's call list upon request, ensuring their communication preferences are respected. eHealth's leadership in technology has defined the company since its founding. Today, eHealth has distinguished itself from other Medicare brokers by deploying leading AI technology at scale, continuing its commitment to improving the customer experience. The expansion of Alice marks another step forward in eHealth's mission to use technology to make healthcare simpler and more accessible for everyone. Alice already handles all after-hours Medicare Advantage inquiries and supports both initial enrollment assistance and service calls during business hours when agents are unavailable. In the future, eHealth plans to extend Alice's capabilities to assist individuals with shopping for other types of health insurance plans. For years, eHealth has leveraged AI and machine learning to match beneficiaries with the most suitable health plans based on their unique needs, including coverage requirements, physicians, and prescription drugs, from a broad catalog of leading national and regional insurers. To experience Alice in action, listen to this demo.공시 • Oct 31eHealth, Inc. to Report Q3, 2025 Results on Nov 05, 2025eHealth, Inc. announced that they will report Q3, 2025 results on Nov 05, 2025공시 • Oct 01eHealth, Inc. Releases Findings from New SurveyeHealth, Inc. released findings from a new survey showing most Medicare beneficiaries find it confusing to shop for a plan during the Annual Enrollment Period (AEP), with about one-third of Medicare Advantage enrollees largely unaware of significant changes expected for the coming year. The survey of more than 1,500 Medicare beneficiaries offers timely insights as millions of Americans will soon make coverage decisions during this year's AEP, which runs from Oct. 15 through Dec. 7, 2025. Key findings from eHealth's survey include: 75% of Medicare beneficiaries said choosing a Medicare plan is confusing. 51% of Medicare beneficiaries intend to review their coverage options this AEP, compared to 63% who said they did so last year. 36% of Medicare Advantage and Part D plan enrollees said they are unaware that significant cost and benefit changes are expected for 2026. 33% of Medicare beneficiaries agree they don't have a good understanding of how Medicare Advantage, Medicare Supplement, and Part D plans differ. 33% of Medicare beneficiaries incorrectly believe Medicare covers GLP-1 drugs for weight loss. 29% of Medicare beneficiaries are unaware that Medicare covers recommended vaccines with no out-of-pocket costs.공시 • Sep 20eHealth, Inc Announces Board and Committee ChangesOn September 17, 2025, Aaron Tolson notified the Board of Directors of eHealth, Inc. he is resigning from the Board, as well as from the Board’s compensation committee, nominating and corporate governance committee and government and regulatory affairs committee, effective immediately. Mr. Tolson was initially appointed to the Board as a designee of Echelon Health SPV, LP pursuant to the terms of the Investment Agreement, dated February 17, 2021, by and between the Company and H.I.G. The resignation of Mr. Tolson was not the result of any disagreement between Mr. Tolson and the Company. On September 17, 2025, the Board appointed Todd Arden as a member of the Board, effective immediately. Mr. Arden was appointed to the Board as a designee of H.I.G. pursuant to the Investment Agreement and to fill the vacancy created by Mr. Tolson’s resignation. Mr. Arden will serve as a Class I director, with a term expiring at the Company’s 2028 annual meeting of stockholders. Mr. Arden was also appointed to the Board’s Compensation Committee, Nominating Committee and Government and Regulatory Affairs Committee. On September 18, 2025, the Board increased the number of directors of the Company from nine to ten and appointed Derrick Duke to serve as a Class I director of the Board, effective immediately, with a term expiring at the Company’s 2028 annual meeting of stockholders. No arrangement or understanding exists between Derrick Duke and any other person pursuant to which he was appointed as a director.공시 • Jul 29eHealth, Inc. Announces CEO ChangeseHealth, Inc. announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4, 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition. Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation. Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services. Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite – first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.Before joining Magellan, Derrick spent nearly 16 years at Health Markets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company's finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019. Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management. Derrick holds a bachelor's degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington.공시 • Jul 24eHealth, Inc. to Report Q2, 2025 Results on Aug 06, 2025eHealth, Inc. announced that they will report Q2, 2025 results on Aug 06, 2025공시 • Apr 30eHealth, Inc. Introduces AI Voice Agents to Enhance Customer Experience in Health Plan SelectioneHealth, Inc. unveiled a new AI-based voice, non-licensed agent designed to streamline the health insurance plan selection process. This launch marks a significant milestone in eHealth's ongoing, multi-year strategy to leverage AI empathetically, enhancing the expertise of licensed insurance agents to provide an exceptional consumer experience. The AI-based voice agents started by handling incoming Medicare calls to eHealth during after-hours, reducing the wait time for consumers who may otherwise need to wait longer to speak with a human screener. The AI-powered voice agents can enhance the customer experience by initiating the customer intake process, gathering personal information, checking initial eligibility, and communicating necessary disclosures. Since launching as a pilot earlier in 2025, among callers served by the AI agents, the program has: Eliminated after-hours wait times and ensured a 100% answer rate. Nearly doubled the percentage of callers (18.5% compared to 34.5%) who expressed interest in purchasing a plan, as compared to human screeners. The AI-based agents have expanded from initially handling after-hours calls to now assisting with incoming Medicare calls during business hours on a pilot basis. In the future, the AI agents are expected to serve people calling eHealth shopping for other types of insurance plans. In addition, a recent eHealth survey of over 500 consumers found significant interest in the use of AI to improve the experience when calling customer service. Among the findings from the survey regarding customer service in general: 74% are willing to answer a few questions from an AI assistant if it means getting faster and better help later in the process. 56% agree that working with an AI assistant can provide them with faster, more accurate help. 66% said long hold times are the biggest frustration when calling customer service, followed by difficulty reaching a real person (59%) and poorly trained agents (42%). Key features of the new eHealth AI-based voice agents: Streamlined information gathering. Using a conversational approach, the AI-based voice agents gather key details, including personal information, initial eligibility, and plan preferences. By streamlining the process, the AI agents can eliminate wait times and reduce the effort required for callers to shop for health benefits, making the plan selection process more accessible for everyone. Enhanced accuracy and cost efficiency. Using advanced algorithms and voice-recognition technology, the AI agents help minimize errors and ensure callers are matched with an appropriate licensed insurance agent to then review appropriate plan options based on location, health care goals and budget. Compared to human screeners, the AI agents are more cost efficient. User-friendly and consistent service: The intuitive experience of the AI-based voice agents enables users to provide initial information more easily and start the plan selection experience, while expediting the process once the caller is connected to a live, licensed insurance agent. The AI agents are designed to answer all customer questions with empathy and patience, with feedback from callers emphasizing feelings of being respected and valued.공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2025eHealth, Inc., Annual General Meeting, Jun 18, 2025.공시 • Apr 24eHealth, Inc. to Report Q1, 2025 Results on May 07, 2025eHealth, Inc. announced that they will report Q1, 2025 results at 12:30 PM, US Eastern Standard Time on May 07, 2025공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.공시 • Feb 13eHealth, Inc. to Report Q4, 2024 Results on Feb 26, 2025eHealth, Inc. announced that they will report Q4, 2024 results on Feb 26, 2025공시 • Jan 29"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for EmployeeseHealth, Inc. announced the launch of Iris by eHealth, an end-to-end Individual Coverage Health Reimbursement Account (ICHRA) solution for employers who want to support employee healthcare but struggle with the unpredictable costs of group health plans. Here's how Iris by eHealth works: The employer determines a flat monthly contribution to be made toward each employee's health coverage, Using eHealth's Iris platform, employees select their own plan from among top insurance companies in their area, By adding their preferred doctors and prescriptions, they can narrow down their choices to those best suited to their personal needs, eHealth's proven customer care team manages enrollments and provides direct support to employees, Once enrolled, the employer's monthly contribution funds some, or all, of the employee's health insurance premiums. There are no plan markups or hidden fees with Iris. eHealth's licensed agents are available nationwide by phone or chat to help employers and their employees find the coverage they need, with a free annual review of plan options.공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.Recent Insider Transactions • Nov 15Independent Director recently sold €98k worth of stockOn the 11th of November, Dale Wolf sold around 20k shares on-market at roughly €4.92 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €229k more than they sold in the last 12 months.Reported Earnings • Nov 07Third quarter 2024 earnings released: US$1.83 loss per share (vs US$1.68 loss in 3Q 2023)Third quarter 2024 results: US$1.83 loss per share (further deteriorated from US$1.68 loss in 3Q 2023). Revenue: US$58.4m (down 9.7% from 3Q 2023). Net loss: US$53.9m (loss widened 14% from 3Q 2023). Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.공시 • Oct 23eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024eHealth, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Aug 11CEO & Director recently bought €187k worth of stockOn the 8th of August, Francis Soistman bought around 50k shares on-market at roughly €3.73 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months.Reported Earnings • Aug 08Second quarter 2024 earnings released: US$1.33 loss per share (vs US$1.18 loss in 2Q 2023)Second quarter 2024 results: US$1.33 loss per share (further deteriorated from US$1.18 loss in 2Q 2023). Revenue: US$65.9m (down 1.4% from 2Q 2023). Net loss: US$39.0m (loss widened 19% from 2Q 2023). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.공시 • Aug 07eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive OfficereHealth, Inc. announced that Fran Soistman will retire from his role as Chief Executive Officer upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Mr. Soistman intends to remain a director on the Company's Board of Directors. Mr. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Mr. Soistman's successor and has engaged Spencer Stuart, to identify and evaluate both internal and external candidates.공시 • Jul 23eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024eHealth, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024공시 • Jul 03+ 4 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 IndexeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index공시 • May 31+ 1 more updateeHealth, Inc. Announces CFO ChangeseHealth, Inc. announced that John Stelben, its chief financial officer (CFO), is returning to retirement and will depart the company at the end of August 2024. Mr. Stelben will serve as a retained advisor through the end of 2024 to ensure a seamless transition. John Dolan, eHealth's chief accounting officer will be appointed SVP, CFO on August 31, 2024. In connection with his role as SVP, CFO, Mr. Dolan will also serve as the company's principal financial and accounting officer.Reported Earnings • May 08First quarter 2024 earnings released: US$0.96 loss per share (vs US$1.01 loss in 1Q 2023)First quarter 2024 results: US$0.96 loss per share (improved from US$1.01 loss in 1Q 2023). Revenue: US$93.0m (up 26% from 1Q 2023). Net loss: US$27.7m (loss narrowed 1.2% from 1Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.공시 • May 08eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. reiterated earnings guidance for the full year ending December 31, 2024. For the year, the company total revenue is expected to be in the range of $450 million to $475 million and GAAP net loss is expected to be in the range of $40 million to $20 million.New Risk • Apr 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$68m net loss in 2 years). Shareholders have been diluted in the past year (4.8% increase in shares outstanding).공시 • Feb 29eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, company expects Total revenue to be in the range of $450 million to $475 million and GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.New Risk • Feb 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$67m Forecast net loss in 3 years: US$14m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$14m net loss in 3 years). Shareholders have been diluted in the past year (3.4% increase in shares outstanding).Reported Earnings • Feb 28Full year 2023 earnings released: US$2.37 loss per share (vs US$4.37 loss in FY 2022)Full year 2023 results: US$2.37 loss per share (improved from US$4.37 loss in FY 2022). Revenue: US$452.9m (up 12% from FY 2022). Net loss: US$66.5m (loss narrowed 44% from FY 2022). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year whereas the company’s share price has fallen by 48% per year.공시 • Feb 27Ehealth, Inc. Unveils "Advisor in the Room" Pilot Program, Bridging the Gap Between Phone and In-Person SupporteHealth, Inc. announced a new pilot program – ‘Advisor in the Room’ – that will transform a traditional phone call into a dynamic, visual experience. This innovative technology will empower eHealth's benefit advisors, who are licensed insurance agents, to instantly appear on a customer's computer or phone screen upon request, fostering a deeper connection and personalized support. How it works: During a phone call, advisors can seamlessly send a secure link to the customer. With a single click, the customer grants permission, and the advisor appears on their screen using secure video technology. This shared visual workspace enables: Transparent plan selection: Advisors can visually guide customers through health plans, plan benefits, and help them select a plan that would meet their needs. Enhanced personal connection: Seeing the advisor fosters trust and understanding, leading to a more positive customer experience. Increased efficiency: Visual communication clarifies explanations, reducing call times and ultimately leading to stronger conversions and better retention. Customer privacy: Customers will be able to maintain their privacy because they will not be visible to the advisor. eHealth's Advisor in the Room technology is expected to roll out for Medicare beneficiaries on a limited basis in Second Quarter 2024, with the goal of making it more broadly available to eHealth customers before Medicare's Annual Enrollment Period in the fall.공시 • Feb 16eHealth, Inc. to Report Q4, 2023 Results on Feb 27, 2024eHealth, Inc. announced that they will report Q4, 2023 results on Feb 27, 2024New Risk • Jan 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).공시 • Nov 21eHealth, Inc. Announces Executive ChangeseHealth, Inc. announced senior leadership changes. Chief Operating Officer and Chief Transformation Officer, Roman Rariy, will depart eHealth at the end of the year after nearly two years of service. Mr. Rariy will be taking on a new role as Chief Executive Officer at a manufacturing company. Chief Marketing Officer, Michelle Barbeau, has been appointed Chief Revenue Officer effective January 1, 2024 and will assume the responsibility for Sales, in addition to her Marketing responsibilities, in the newly formed Revenue Organization.Reported Earnings • Nov 10Third quarter 2023 earnings released: US$1.68 loss per share (vs US$1.72 loss in 3Q 2022)Third quarter 2023 results: US$1.68 loss per share. Revenue: US$64.7m (up 21% from 3Q 2022). Net loss: US$47.2m (flat on 3Q 2022). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany.공시 • Nov 10eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023eHealth, Inc. provided earnings guidance of the year ending December 31, 2023. For the period, the company expects total revenue to be in the range of $439 million to $459 million and GAAP net loss is expected to be in the range of $46 million to $26 million.공시 • Oct 26eHealth, Inc. to Report Q3, 2023 Results on Nov 08, 2023eHealth, Inc. announced that they will report Q3, 2023 results on Nov 08, 2023공시 • Oct 12Al Redmer Jr. Joins eHealth's Public Policy Advisory CommitteeeHealth, Inc. announced that Al Redmer Jr. has joined its Public Policy Advisory Committee, a panel of distinguished experts gathered to inform the company, the public, and policymakers on ideas for improving health care practices in both the public and private sectors. Mr. Redmer twice served as the Maryland Insurance Commissioner, from 2003 to 2005 and again from 2015 to 2020. During his tenure he also served as Chair of the National Association of Insurance Commissioners'Health Insurance and Managed Care Committee. From 1991 to 2003 Mr. Redmer was a Member of the Maryland House of Delegates. Mr. Redmer also served as CEO of Coventry Healthcare of Delaware. Other current members of eHealth's Public Policy Advisory Committee include Steve Beshear, former Governor of Kentucky; Jerome Adams, MD, former Surgeon General of the United States; Bobby Jindal, former Governor of Louisiana; Susan Kennedy, who served as Chief of Staff to former California Governor Arnold Schwarzenegger; and Woodrow "Woody" Myers, MD, former Health Commissioner of New York City and of the state of Indiana.Recent Insider Transactions • Sep 21Independent Chairman of the Board recently bought €99k worth of stockOn the 15th of September, Dale Wolf bought around 15k shares on-market at roughly €6.60 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €161k worth in shares.New Risk • Aug 10New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$9.0m net loss in 3 years). Shareholders have been diluted in the past year (3.1% increase in shares outstanding).Reported Earnings • Aug 09Second quarter 2023 earnings released: US$1.18 loss per share (vs US$1.65 loss in 2Q 2022)Second quarter 2023 results: US$1.18 loss per share (improved from US$1.65 loss in 2Q 2022). Revenue: US$66.8m (up 33% from 2Q 2022). Net loss: US$32.9m (loss narrowed 27% from 2Q 2022). Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance.공시 • Aug 09eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million.공시 • Jul 26eHealth, Inc. to Report Q2, 2023 Results on Aug 08, 2023eHealth, Inc. announced that they will report Q2, 2023 results on Aug 08, 2023Recent Insider Transactions • Jun 04Independent Chairman of the Board recently bought €77k worth of stockOn the 31st of May, Dale Wolf bought around 13k shares on-market at roughly €5.99 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €62k worth in shares.Reported Earnings • May 10First quarter 2023 earnings released: US$1.01 loss per share (vs US$1.47 loss in 1Q 2022)First quarter 2023 results: US$1.01 loss per share (improved from US$1.47 loss in 1Q 2022). Revenue: US$73.7m (down 30% from 1Q 2022). Net loss: US$28.0m (loss narrowed 30% from 1Q 2022). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 40 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 01Full year 2022 earnings released: US$4.37 loss per share (vs US$4.59 loss in FY 2021)Full year 2022 results: US$4.37 loss per share (improved from US$4.59 loss in FY 2021). Revenue: US$405.4m (down 25% from FY 2021). Net loss: US$119.4m (loss narrowed 2.9% from FY 2021). Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.Buying Opportunity • Feb 15Now 22% undervaluedOver the last 90 days, the stock is up 171%. The fair value is estimated to be €10.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 1.1% in 2 years. Earnings is forecast to grow by 35% in the next 2 years.공시 • Feb 09eHealth, Inc. Announces Randall Livingston Not Stand for Re-Election to the Board of DirectorseHealth, Inc. announced that Randall Livingston will not stand for re-election to the Board of Directors and will step down when his current term expires at the Company’s 2023 annual meeting of shareholders.공시 • Feb 07eHealth, Inc. Welcomes Back Lara Sasken as Senior Vice President, CommunicationseHealth, Inc. announced the return of Lara Sasken as Senior Vice President of Communications. Prior to that,Lara held senior communications leadership roles at SurveyMonkey, Facebook, and GoPro.공시 • Jan 31eHealth, Inc. to Report Q4, 2022 Results on Feb 28, 2023eHealth, Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 28, 2023공시 • Jan 25+ 1 more updateeHealth, Inc. Provides Earning Guidance for Year Ended December 31, 2022eHealth, Inc. provided earning guidance for year ended December 31, 2022. For year ended December 31, 2022, revenue is expected to be in the range of $395 to $405 million as compared to the company’s guidance of $375 to $395 million and GAAP net loss is expected to be in the range of $93 to $88 million as compared to the company’s guidance of $115 to $92 million.공시 • Jan 24eHealth, Inc. Appoints Ketan Babaria as SVP and Chief Digital OfficereHealth, Inc. announced the appointment of Ketan Babaria as SVP, Chief Digital Officer. Mr. Babaria joins eHealth from M1 Finance where he served as Chief Product Officer, responsible for defining the company's product vision, strategy, and roadmap to drive growth and profitability. Prior to M1 Finance, Mr. Babaria served as Chief Product Officer at Roofstock, Head of Product at LifeLock, and Sr. Director and Head of Product, D3 Incubation Unit at Capital One.Recent Insider Transactions • Nov 26CEO & Director recently bought €240k worth of stockOn the 22nd of November, Francis Soistman bought around 80k shares on-market at roughly €3.00 per share. This transaction amounted to 23% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months.Board Change • Nov 16High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Nov 15+ 1 more updateeHealth, Inc. Announces Management ChangesEffective November 14, 2022, John J. Stelben will join eHealth, Inc. (the “Company”) as its new senior vice president of the Company. Mr. Stelben will succeed Christine Janofsky as the Company’s senior vice president. On November 8, 2022, Ms. Janofsky's employment with the Company was terminated effective November 11, 2022. Mr. Stelben, age 61, most recently served as CFO CVS Integration for Aetna from 2017 to 2018. Prior to that, Mr. Stelben served in a number of positions of increasing responsibility at Aetna, including CFO Government Programs, which included Medicare, Medicaid and public exchange businesses, from 2013 to 2017. Mr. Stelben also served in various senior leadership roles at Coventry Health Care, Inc, for over 18 years. Mr. Stelben is a certified public accountant (inactive) and holds a B.S. degree in accounting from Fairfield University.Reported Earnings • Nov 09Third quarter 2022 earnings released: US$1.72 loss per share (vs US$2.24 loss in 3Q 2021)Third quarter 2022 results: US$1.72 loss per share (improved from US$2.24 loss in 3Q 2021). Revenue: US$53.4m (down 17% from 3Q 2021). Net loss: US$47.0m (loss narrowed 22% from 3Q 2021). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.공시 • Nov 08+ 1 more updateeHealth, Inc. Announces Impairment Charges for the Third Quarter Ended September 30, 2022eHealth, Inc. announced impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported Impairment charges of $3,734,000.공시 • Oct 25eHealth, Inc. to Report Q3, 2022 Results on Nov 07, 2022eHealth, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022공시 • Oct 11eHealth, Inc. Appoints Jana Brown as Senior Vice President and Chief People OfficereHealth, Inc. announced the appointment of Jana Brown as SVP, Chief People Officer. Ms. Brown joins eHealth from Centurion Health, an independent subsidiary of Centene, where she served as EVP and Chief Human Resource Officer, responsible for human capital strategy including Talent Acquisition, Talent Management, Employee Relations, Diversity, Equity & Inclusion, Learning & Development, HR Operations, and Total Rewards. Prior to Centurion Health, she served as Head of Talent and Total Rewards at CareSource HealthPlan. She also served as SVP, HR Chief Operating Officer, and Business Partner at TIAA.공시 • Sep 09eHealth Appoints Michelle Barbeau Chief Marketing OfficereHealth, Inc. announced the appointment of Michelle Barbeau as Chief Marketing Officer. Ms. Barbeau is a proven leader with a wealth of experience in the healthcare industry. She comes to eHealth from Ableto, a provider of virtual mental health services, where she led their marketing and communications strategy with a focus on designing experiences that drive loyalty and high ROI. Prior to this, she served four years as a Vice President at UnitedHealthcare, where she transformed a team focused on employer and individual member engagement. She also served eight years in marketing management roles at General Mills.공시 • Aug 09+ 1 more updateeHealth, Inc. Announces Departure of Phillip Morelock as Chief Digital OfficerOn August 3, 2022, Phillip Morelock’s employment as Chief Digital Officer of eHealth, Inc. ceased and he departed the Company.Reported Earnings • Aug 09Second quarter 2022 earnings released: US$1.65 loss per share (vs US$0.86 loss in 2Q 2021)Second quarter 2022 results: US$1.65 loss per share (down from US$0.86 loss in 2Q 2021). Revenue: US$50.4m (down 48% from 2Q 2021). Net loss: US$45.0m (loss widened 97% from 2Q 2021). Over the next year, revenue is forecast to grow 3.5%, compared to a 26% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.공시 • Jul 28eHealth, Inc. to Report Q2, 2022 Results on Aug 08, 2022eHealth, Inc. announced that they will report Q2, 2022 results on Aug 08, 2022공시 • Jun 30eHealth, Inc. Appoints Gavin Galimi as Senior Vice President, General Counsel and Corporate SecretaryeHealth, Inc. announced the appointment of Gavin Galimi as Senior Vice President, General Counsel and Corporate Secretary. Mr. Galimi comes to eHealth with a wealth of experience in the health insurance sector, including 15 years at UnitedHealth Group. He most recently served as General Counsel for UnitedHealthcare Specialty Benefits. In 2017, he co-founded Stratagem Investments, a private equity firm focused on solving society's inequities and disparities in access to good care. He earned his JD at the University of Southern California and his BS in Biological Sciences and BA in International Relations, each from USC.공시 • Jun 04eHealth, Inc. Announces Management ChangesOn May 31, 2022, eHealth, Inc. appointed John Dolan as chief accounting officer and principal accounting officer of the Company, effective May 31, 2022. Mr. Dolan assumes responsibility as principal accounting officer from Christine Janofsky, who will continue her role as the Company’s chief financial officer and principal financial officer. Mr. Dolan, 54, previously served as deputy controller of The Bank of New York Mellon Corporation, from March 2017 to May 2022. Mr. Dolan also held various senior positions at American Express Company from 2004 to 2017, including most recently as vice president, Americas and global accounting policies controller. Mr. Dolan is a certified public accountant and holds a B.S in accounting from Manhattan College.Reported Earnings • May 04First quarter 2022 earnings released: US$1.28 loss per share (vs US$0.03 loss in 1Q 2021)First quarter 2022 results: US$1.28 loss per share (down from US$0.03 loss in 1Q 2021). Revenue: US$105.3m (down 22% from 1Q 2021). Net loss: US$35.0m (loss widened US$34.2m from 1Q 2021). Over the next year, revenue is expected to shrink by 7.6% compared to a 20% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.공시 • May 03eHealth, Inc., Annual General Meeting, Jun 15, 2022eHealth, Inc., Annual General Meeting, Jun 15, 2022, at 08:30 Pacific Standard Time. Agenda: To elect the three Class I director nominees to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal; to ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2022; to vote to approve, on an advisory basis, the compensation of Named Executive Officers; to vote to approve an amendment to our Amended and Restated 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares; and to transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Independent Director Randy Livingston is the most experienced director on the board, commencing their role in 2008. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Apr 21eHealth, Inc. to Report Q1, 2022 Results on May 03, 2022eHealth, Inc. announced that they will report Q1, 2022 results on May 03, 2022Recent Insider Transactions • Mar 21Independent Chairman of the Board recently bought €187k worth of stockOn the 14th of March, Dale Wolf bought around 20k shares on-market at roughly €9.36 per share. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares.Recent Insider Transactions • Mar 08Chief Digital Officer recently sold €75k worth of stockOn the 4th of March, Phillip Morelock sold around 7k shares on-market at roughly €10.77 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €2.3m more than they sold in the last 12 months.공시 • Mar 04Ehealth, Inc. Corrects Earnings Guidance for the Full Year Ending December 31, 2022eHealth, Inc. corrected earnings guidance for the full year ending December 31, 2022. The guidance for GAAP net loss for the full year ending December 31, 2022 in the section titled “2022 Guidance” of the March 1, 2022 press release is corrected as set forth below: --GAAP net loss for the full year ending December 31, 2022 is expected to be in the range of $106.0 million to $83.0 million, corrected from a range of $147.0 million to $124.0 million. Total revenue is expected to be in the range of $448.0 million to $470.0 million.공시 • Mar 03eHealth, Inc. Provides Earnings Guidance for the Full year Ending December 31, 2022eHealth, Inc. provided earnings guidance for the full year ending December 31, 2022. The company expects total revenue to be in the range of $448.0 million to $470.0 million and GAAP net loss is expected to be in the range of $147.0 million to $124.0 million.이익 및 매출 성장 예측DB:M5V - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028485-5N/AN/A112/31/2027447-284029512/31/2026429-34331953/31/2026529-19-81-67N/A12/31/2025554-10-41-25N/A9/30/20255431-33-17N/A6/30/2025547-8-38-21N/A3/31/2025553-17-26-12N/A12/31/2024532-35-31-18N/A9/30/2024465-79-36-24N/A6/30/2024471-72-31-19N/A3/31/2024472-66-83N/A12/31/2023453-67-17-7N/A9/30/2023402-96-38N/A6/30/2023390-95-83N/A3/31/2023374-108-27-13N/A12/31/2022405-119-42-27N/A9/30/2022453-171-128-111N/A6/30/2022463-184-171-152N/A3/31/2022509-162-178-158N/A12/31/2021538-123-183-163N/A9/30/2021588-24-179-157N/A6/30/202161822-106-85N/A3/31/202161141-97-74N/A12/31/202058345-132-108N/A9/30/202059174-91-68N/A6/30/202056778-107-85N/A3/31/202054475-95-75N/A12/31/201950667N/A-71N/A9/30/20193394N/A-23N/A6/30/20193106N/A-12N/A3/31/20192770N/A-1N/A12/31/20182510N/A-3N/A9/30/20182002N/A-5N/A6/30/20181909N/A-13N/A3/31/201819220N/A-13N/A12/31/201719125N/A-16N/A9/30/2017151-19N/A-10N/A6/30/2017152-23N/A4N/A3/31/2017155-22N/A8N/A12/31/20161930N/A4N/A9/30/20161930N/A10N/A6/30/20161999N/A19N/A3/31/201620215N/A30N/A12/31/2015190-5N/A14N/A9/30/2015184-12N/A8N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: M5V 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 vs 시장: M5V 향후 3년 동안 수익성이 없을 것으로 예상됩니다.고성장 수익: M5V 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 대 시장: M5V 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -5.7%).고성장 매출: M5V 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -5.7%).주당순이익 성장 예측향후 자기자본이익률미래 ROE: M5V는 3년 뒤에도 수익성이 없을 것으로 전망됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YInsurance 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/07 07:23종가2026/07/07 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스eHealth, Inc.는 24명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Steven ValiquetteBarclaysNathaniel SchindlerBofA Global ResearchRichard FetykoBrean Capital Historical (Janney Montgomery)21명의 분석가 더 보기
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.
공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.
공시 • May 08eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. reiterated earnings guidance for the full year ending December 31, 2024. For the year, the company total revenue is expected to be in the range of $450 million to $475 million and GAAP net loss is expected to be in the range of $40 million to $20 million.
공시 • Feb 29eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, company expects Total revenue to be in the range of $450 million to $475 million and GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.
공시 • Nov 10eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023eHealth, Inc. provided earnings guidance of the year ending December 31, 2023. For the period, the company expects total revenue to be in the range of $439 million to $459 million and GAAP net loss is expected to be in the range of $46 million to $26 million.
New Risk • Jul 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$22m net loss in 2 years). Market cap is less than US$100m (€47.5m market cap, or US$54.3m).
공시 • Jun 29+ 10 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Value BenchmarkeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Value Benchmark
공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2026eHealth, Inc., Annual General Meeting, Jun 18, 2026.
공시 • Apr 23eHealth, Inc. to Report Q1, 2026 Results on May 06, 2026eHealth, Inc. announced that they will report Q1, 2026 results on May 06, 2026
공시 • Apr 17eHealth Announces Final Expense Life Insurance PlanseHealth had announced it now offers Final Expense life insurance plans, helping Americans and their families prepare for funeral and burial or cremation expenses. The new plans are part of eHealth's strategy to better meet the coverage and wellness needs of individuals and families, offering an expanded portfolio of plans, services and support to help consumers live healthier, more financially secure lives. A new eHealth survey of over 1,000 Americans aged 65 and older found many people are unprepared to cover end-of-life expenses. Key survey findings include: 69% underestimate the average cost of a funeral with viewing and cremation, while 35% underestimate the average cost of a funeral with burial. 62% plan to be cremated, while 23% prefer to be buried; 15% don't know or have no preference. 47% worry about burdening loved ones with the cost of a funeral and burial or cremation. Among survey respondents living on an income of less than $50,000 per year: 56% worry about burdening their loved ones with the cost of a funeral and burial or cremation. 33% have no insurance or money set aside to help cover these end-of-life expenses. EHealth's Final Expense plans are offered through Mutual of Omaha and available by phone, allowing licensed insurance agents to address coverage options as part of a broader, personalized financial protection discussion. The policies can provide tax-free funds for various purposes, including funeral and burial or cremation expenses, outstanding medical bills, travel costs, legal fees, or other related needs. Two types of Final Expense plans are available: Level Benefit Plans, offered to people ages 45 to 85, with coverage amounts ranging from $2,000 to $50,000. Graded Benefit Plans, offered to people ages 45 to 80, with coverage amounts ranging from $2,000 to $20,000. Applicants are not required to undergo a medical exam to qualify for coverage. Instead, eligibility is determined through responses to a limited set of health questions covering a lookback period of approximately two to four years. The plans are designed to be affordable and provide beneficiaries with quick access to guaranteed funds, helping reduce financial stress during a difficult time. The average cost of a funeral with a viewing and burial exceeds $8,000, while the average cost of a funeral with a viewing and cremation is more than $6,000. Specific plan availability may vary by state; some plans may not be available in Arkansas, Montana, New York, and North Carolina. Coverage and premiums may vary based on qualifying factors.
공시 • Apr 01Andrea Brimmer to Step Down from Board of Directors of eHealth, Inc. on June 18, 2026eHealth, Inc. announced that Andrea Brimmer will not stand for re-election to the Company's Board of Directors and will step down when her current term expires at the Company's next annual meeting of shareholders to be held on June 18, 2026. Ms. Brimmer will continue to serve as a member of the Board until the expiration of her term at the Company's upcoming annual meeting.
공시 • Feb 10eHealth, Inc. to Report Q4, 2025 Results on Feb 25, 2026eHealth, Inc. announced that they will report Q4, 2025 results on Feb 25, 2026
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.
공시 • Nov 12eHealth Advances its AI Strategy with Expanded Voice Agent CapabilitieseHealth announced the expanded use of Alice, its AI-powered voice agent. Alice has expanded beyond its initial use for shopping and initial enrollment telephone support and is now assisting with post-enrollment and general service calls from Medicare Advantage beneficiaries, helping to efficiently address and resolve common inquiries such as: Application status: Alice provides customers with general information on their application status as provided by the health plan. Soon, she will also be able to look up specific details and inform callers exactly where their application is with the health plan in the process. ID card inquiries: Alice informs customers when they generally can expect to receive their insurance ID cards and, if necessary, directs them to contact their health plan for further assistance. Billing questions: Alice provides customers with direct billing contact phone numbers for their respective health plan, making it easier for individuals to access assistance when billing support is required. Do Not Call requests: Alice can initiate steps to remove customers from eHealth's call list upon request, ensuring their communication preferences are respected. eHealth's leadership in technology has defined the company since its founding. Today, eHealth has distinguished itself from other Medicare brokers by deploying leading AI technology at scale, continuing its commitment to improving the customer experience. The expansion of Alice marks another step forward in eHealth's mission to use technology to make healthcare simpler and more accessible for everyone. Alice already handles all after-hours Medicare Advantage inquiries and supports both initial enrollment assistance and service calls during business hours when agents are unavailable. In the future, eHealth plans to extend Alice's capabilities to assist individuals with shopping for other types of health insurance plans. For years, eHealth has leveraged AI and machine learning to match beneficiaries with the most suitable health plans based on their unique needs, including coverage requirements, physicians, and prescription drugs, from a broad catalog of leading national and regional insurers. To experience Alice in action, listen to this demo.
공시 • Oct 31eHealth, Inc. to Report Q3, 2025 Results on Nov 05, 2025eHealth, Inc. announced that they will report Q3, 2025 results on Nov 05, 2025
공시 • Oct 01eHealth, Inc. Releases Findings from New SurveyeHealth, Inc. released findings from a new survey showing most Medicare beneficiaries find it confusing to shop for a plan during the Annual Enrollment Period (AEP), with about one-third of Medicare Advantage enrollees largely unaware of significant changes expected for the coming year. The survey of more than 1,500 Medicare beneficiaries offers timely insights as millions of Americans will soon make coverage decisions during this year's AEP, which runs from Oct. 15 through Dec. 7, 2025. Key findings from eHealth's survey include: 75% of Medicare beneficiaries said choosing a Medicare plan is confusing. 51% of Medicare beneficiaries intend to review their coverage options this AEP, compared to 63% who said they did so last year. 36% of Medicare Advantage and Part D plan enrollees said they are unaware that significant cost and benefit changes are expected for 2026. 33% of Medicare beneficiaries agree they don't have a good understanding of how Medicare Advantage, Medicare Supplement, and Part D plans differ. 33% of Medicare beneficiaries incorrectly believe Medicare covers GLP-1 drugs for weight loss. 29% of Medicare beneficiaries are unaware that Medicare covers recommended vaccines with no out-of-pocket costs.
공시 • Sep 20eHealth, Inc Announces Board and Committee ChangesOn September 17, 2025, Aaron Tolson notified the Board of Directors of eHealth, Inc. he is resigning from the Board, as well as from the Board’s compensation committee, nominating and corporate governance committee and government and regulatory affairs committee, effective immediately. Mr. Tolson was initially appointed to the Board as a designee of Echelon Health SPV, LP pursuant to the terms of the Investment Agreement, dated February 17, 2021, by and between the Company and H.I.G. The resignation of Mr. Tolson was not the result of any disagreement between Mr. Tolson and the Company. On September 17, 2025, the Board appointed Todd Arden as a member of the Board, effective immediately. Mr. Arden was appointed to the Board as a designee of H.I.G. pursuant to the Investment Agreement and to fill the vacancy created by Mr. Tolson’s resignation. Mr. Arden will serve as a Class I director, with a term expiring at the Company’s 2028 annual meeting of stockholders. Mr. Arden was also appointed to the Board’s Compensation Committee, Nominating Committee and Government and Regulatory Affairs Committee. On September 18, 2025, the Board increased the number of directors of the Company from nine to ten and appointed Derrick Duke to serve as a Class I director of the Board, effective immediately, with a term expiring at the Company’s 2028 annual meeting of stockholders. No arrangement or understanding exists between Derrick Duke and any other person pursuant to which he was appointed as a director.
공시 • Jul 29eHealth, Inc. Announces CEO ChangeseHealth, Inc. announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4, 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition. Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation. Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services. Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite – first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.Before joining Magellan, Derrick spent nearly 16 years at Health Markets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company's finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019. Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management. Derrick holds a bachelor's degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington.
공시 • Jul 24eHealth, Inc. to Report Q2, 2025 Results on Aug 06, 2025eHealth, Inc. announced that they will report Q2, 2025 results on Aug 06, 2025
공시 • Apr 30eHealth, Inc. Introduces AI Voice Agents to Enhance Customer Experience in Health Plan SelectioneHealth, Inc. unveiled a new AI-based voice, non-licensed agent designed to streamline the health insurance plan selection process. This launch marks a significant milestone in eHealth's ongoing, multi-year strategy to leverage AI empathetically, enhancing the expertise of licensed insurance agents to provide an exceptional consumer experience. The AI-based voice agents started by handling incoming Medicare calls to eHealth during after-hours, reducing the wait time for consumers who may otherwise need to wait longer to speak with a human screener. The AI-powered voice agents can enhance the customer experience by initiating the customer intake process, gathering personal information, checking initial eligibility, and communicating necessary disclosures. Since launching as a pilot earlier in 2025, among callers served by the AI agents, the program has: Eliminated after-hours wait times and ensured a 100% answer rate. Nearly doubled the percentage of callers (18.5% compared to 34.5%) who expressed interest in purchasing a plan, as compared to human screeners. The AI-based agents have expanded from initially handling after-hours calls to now assisting with incoming Medicare calls during business hours on a pilot basis. In the future, the AI agents are expected to serve people calling eHealth shopping for other types of insurance plans. In addition, a recent eHealth survey of over 500 consumers found significant interest in the use of AI to improve the experience when calling customer service. Among the findings from the survey regarding customer service in general: 74% are willing to answer a few questions from an AI assistant if it means getting faster and better help later in the process. 56% agree that working with an AI assistant can provide them with faster, more accurate help. 66% said long hold times are the biggest frustration when calling customer service, followed by difficulty reaching a real person (59%) and poorly trained agents (42%). Key features of the new eHealth AI-based voice agents: Streamlined information gathering. Using a conversational approach, the AI-based voice agents gather key details, including personal information, initial eligibility, and plan preferences. By streamlining the process, the AI agents can eliminate wait times and reduce the effort required for callers to shop for health benefits, making the plan selection process more accessible for everyone. Enhanced accuracy and cost efficiency. Using advanced algorithms and voice-recognition technology, the AI agents help minimize errors and ensure callers are matched with an appropriate licensed insurance agent to then review appropriate plan options based on location, health care goals and budget. Compared to human screeners, the AI agents are more cost efficient. User-friendly and consistent service: The intuitive experience of the AI-based voice agents enables users to provide initial information more easily and start the plan selection experience, while expediting the process once the caller is connected to a live, licensed insurance agent. The AI agents are designed to answer all customer questions with empathy and patience, with feedback from callers emphasizing feelings of being respected and valued.
공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2025eHealth, Inc., Annual General Meeting, Jun 18, 2025.
공시 • Apr 24eHealth, Inc. to Report Q1, 2025 Results on May 07, 2025eHealth, Inc. announced that they will report Q1, 2025 results at 12:30 PM, US Eastern Standard Time on May 07, 2025
공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.
공시 • Feb 13eHealth, Inc. to Report Q4, 2024 Results on Feb 26, 2025eHealth, Inc. announced that they will report Q4, 2024 results on Feb 26, 2025
공시 • Jan 29"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for EmployeeseHealth, Inc. announced the launch of Iris by eHealth, an end-to-end Individual Coverage Health Reimbursement Account (ICHRA) solution for employers who want to support employee healthcare but struggle with the unpredictable costs of group health plans. Here's how Iris by eHealth works: The employer determines a flat monthly contribution to be made toward each employee's health coverage, Using eHealth's Iris platform, employees select their own plan from among top insurance companies in their area, By adding their preferred doctors and prescriptions, they can narrow down their choices to those best suited to their personal needs, eHealth's proven customer care team manages enrollments and provides direct support to employees, Once enrolled, the employer's monthly contribution funds some, or all, of the employee's health insurance premiums. There are no plan markups or hidden fees with Iris. eHealth's licensed agents are available nationwide by phone or chat to help employers and their employees find the coverage they need, with a free annual review of plan options.
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.
Recent Insider Transactions • Nov 15Independent Director recently sold €98k worth of stockOn the 11th of November, Dale Wolf sold around 20k shares on-market at roughly €4.92 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €229k more than they sold in the last 12 months.
Reported Earnings • Nov 07Third quarter 2024 earnings released: US$1.83 loss per share (vs US$1.68 loss in 3Q 2023)Third quarter 2024 results: US$1.83 loss per share (further deteriorated from US$1.68 loss in 3Q 2023). Revenue: US$58.4m (down 9.7% from 3Q 2023). Net loss: US$53.9m (loss widened 14% from 3Q 2023). Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.
공시 • Oct 23eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024eHealth, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Aug 11CEO & Director recently bought €187k worth of stockOn the 8th of August, Francis Soistman bought around 50k shares on-market at roughly €3.73 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months.
Reported Earnings • Aug 08Second quarter 2024 earnings released: US$1.33 loss per share (vs US$1.18 loss in 2Q 2023)Second quarter 2024 results: US$1.33 loss per share (further deteriorated from US$1.18 loss in 2Q 2023). Revenue: US$65.9m (down 1.4% from 2Q 2023). Net loss: US$39.0m (loss widened 19% from 2Q 2023). Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.
공시 • Aug 07eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive OfficereHealth, Inc. announced that Fran Soistman will retire from his role as Chief Executive Officer upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Mr. Soistman intends to remain a director on the Company's Board of Directors. Mr. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Mr. Soistman's successor and has engaged Spencer Stuart, to identify and evaluate both internal and external candidates.
공시 • Jul 23eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024eHealth, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024
공시 • Jul 03+ 4 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 IndexeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index
공시 • May 31+ 1 more updateeHealth, Inc. Announces CFO ChangeseHealth, Inc. announced that John Stelben, its chief financial officer (CFO), is returning to retirement and will depart the company at the end of August 2024. Mr. Stelben will serve as a retained advisor through the end of 2024 to ensure a seamless transition. John Dolan, eHealth's chief accounting officer will be appointed SVP, CFO on August 31, 2024. In connection with his role as SVP, CFO, Mr. Dolan will also serve as the company's principal financial and accounting officer.
Reported Earnings • May 08First quarter 2024 earnings released: US$0.96 loss per share (vs US$1.01 loss in 1Q 2023)First quarter 2024 results: US$0.96 loss per share (improved from US$1.01 loss in 1Q 2023). Revenue: US$93.0m (up 26% from 1Q 2023). Net loss: US$27.7m (loss narrowed 1.2% from 1Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings.
공시 • May 08eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. reiterated earnings guidance for the full year ending December 31, 2024. For the year, the company total revenue is expected to be in the range of $450 million to $475 million and GAAP net loss is expected to be in the range of $40 million to $20 million.
New Risk • Apr 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.0% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 3.0% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$68m net loss in 2 years). Shareholders have been diluted in the past year (4.8% increase in shares outstanding).
공시 • Feb 29eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, company expects Total revenue to be in the range of $450 million to $475 million and GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.
New Risk • Feb 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$67m Forecast net loss in 3 years: US$14m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$14m net loss in 3 years). Shareholders have been diluted in the past year (3.4% increase in shares outstanding).
Reported Earnings • Feb 28Full year 2023 earnings released: US$2.37 loss per share (vs US$4.37 loss in FY 2022)Full year 2023 results: US$2.37 loss per share (improved from US$4.37 loss in FY 2022). Revenue: US$452.9m (up 12% from FY 2022). Net loss: US$66.5m (loss narrowed 44% from FY 2022). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year whereas the company’s share price has fallen by 48% per year.
공시 • Feb 27Ehealth, Inc. Unveils "Advisor in the Room" Pilot Program, Bridging the Gap Between Phone and In-Person SupporteHealth, Inc. announced a new pilot program – ‘Advisor in the Room’ – that will transform a traditional phone call into a dynamic, visual experience. This innovative technology will empower eHealth's benefit advisors, who are licensed insurance agents, to instantly appear on a customer's computer or phone screen upon request, fostering a deeper connection and personalized support. How it works: During a phone call, advisors can seamlessly send a secure link to the customer. With a single click, the customer grants permission, and the advisor appears on their screen using secure video technology. This shared visual workspace enables: Transparent plan selection: Advisors can visually guide customers through health plans, plan benefits, and help them select a plan that would meet their needs. Enhanced personal connection: Seeing the advisor fosters trust and understanding, leading to a more positive customer experience. Increased efficiency: Visual communication clarifies explanations, reducing call times and ultimately leading to stronger conversions and better retention. Customer privacy: Customers will be able to maintain their privacy because they will not be visible to the advisor. eHealth's Advisor in the Room technology is expected to roll out for Medicare beneficiaries on a limited basis in Second Quarter 2024, with the goal of making it more broadly available to eHealth customers before Medicare's Annual Enrollment Period in the fall.
공시 • Feb 16eHealth, Inc. to Report Q4, 2023 Results on Feb 27, 2024eHealth, Inc. announced that they will report Q4, 2023 results on Feb 27, 2024
New Risk • Jan 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).
공시 • Nov 21eHealth, Inc. Announces Executive ChangeseHealth, Inc. announced senior leadership changes. Chief Operating Officer and Chief Transformation Officer, Roman Rariy, will depart eHealth at the end of the year after nearly two years of service. Mr. Rariy will be taking on a new role as Chief Executive Officer at a manufacturing company. Chief Marketing Officer, Michelle Barbeau, has been appointed Chief Revenue Officer effective January 1, 2024 and will assume the responsibility for Sales, in addition to her Marketing responsibilities, in the newly formed Revenue Organization.
Reported Earnings • Nov 10Third quarter 2023 earnings released: US$1.68 loss per share (vs US$1.72 loss in 3Q 2022)Third quarter 2023 results: US$1.68 loss per share. Revenue: US$64.7m (up 21% from 3Q 2022). Net loss: US$47.2m (flat on 3Q 2022). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany.
공시 • Nov 10eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023eHealth, Inc. provided earnings guidance of the year ending December 31, 2023. For the period, the company expects total revenue to be in the range of $439 million to $459 million and GAAP net loss is expected to be in the range of $46 million to $26 million.
공시 • Oct 26eHealth, Inc. to Report Q3, 2023 Results on Nov 08, 2023eHealth, Inc. announced that they will report Q3, 2023 results on Nov 08, 2023
공시 • Oct 12Al Redmer Jr. Joins eHealth's Public Policy Advisory CommitteeeHealth, Inc. announced that Al Redmer Jr. has joined its Public Policy Advisory Committee, a panel of distinguished experts gathered to inform the company, the public, and policymakers on ideas for improving health care practices in both the public and private sectors. Mr. Redmer twice served as the Maryland Insurance Commissioner, from 2003 to 2005 and again from 2015 to 2020. During his tenure he also served as Chair of the National Association of Insurance Commissioners'Health Insurance and Managed Care Committee. From 1991 to 2003 Mr. Redmer was a Member of the Maryland House of Delegates. Mr. Redmer also served as CEO of Coventry Healthcare of Delaware. Other current members of eHealth's Public Policy Advisory Committee include Steve Beshear, former Governor of Kentucky; Jerome Adams, MD, former Surgeon General of the United States; Bobby Jindal, former Governor of Louisiana; Susan Kennedy, who served as Chief of Staff to former California Governor Arnold Schwarzenegger; and Woodrow "Woody" Myers, MD, former Health Commissioner of New York City and of the state of Indiana.
Recent Insider Transactions • Sep 21Independent Chairman of the Board recently bought €99k worth of stockOn the 15th of September, Dale Wolf bought around 15k shares on-market at roughly €6.60 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €161k worth in shares.
New Risk • Aug 10New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$9.0m net loss in 3 years). Shareholders have been diluted in the past year (3.1% increase in shares outstanding).
Reported Earnings • Aug 09Second quarter 2023 earnings released: US$1.18 loss per share (vs US$1.65 loss in 2Q 2022)Second quarter 2023 results: US$1.18 loss per share (improved from US$1.65 loss in 2Q 2022). Revenue: US$66.8m (up 33% from 2Q 2022). Net loss: US$32.9m (loss narrowed 27% from 2Q 2022). Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance.
공시 • Aug 09eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023eHealth, Inc. revised earnings guidance for the full year ending December 31, 2023. Total revenue is expected to be in the range of $439 million to $459 million compared to prior guidance of $420 million to $440 million. GAAP net loss is expected to be in the range of $46 million to $26 million compared to prior guidance of $55 million to $35 million.
공시 • Jul 26eHealth, Inc. to Report Q2, 2023 Results on Aug 08, 2023eHealth, Inc. announced that they will report Q2, 2023 results on Aug 08, 2023
Recent Insider Transactions • Jun 04Independent Chairman of the Board recently bought €77k worth of stockOn the 31st of May, Dale Wolf bought around 13k shares on-market at roughly €5.99 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €62k worth in shares.
Reported Earnings • May 10First quarter 2023 earnings released: US$1.01 loss per share (vs US$1.47 loss in 1Q 2022)First quarter 2023 results: US$1.01 loss per share (improved from US$1.47 loss in 1Q 2022). Revenue: US$73.7m (down 30% from 1Q 2022). Net loss: US$28.0m (loss narrowed 30% from 1Q 2022). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 40 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 01Full year 2022 earnings released: US$4.37 loss per share (vs US$4.59 loss in FY 2021)Full year 2022 results: US$4.37 loss per share (improved from US$4.59 loss in FY 2021). Revenue: US$405.4m (down 25% from FY 2021). Net loss: US$119.4m (loss narrowed 2.9% from FY 2021). Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance.
Buying Opportunity • Feb 15Now 22% undervaluedOver the last 90 days, the stock is up 171%. The fair value is estimated to be €10.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 1.1% in 2 years. Earnings is forecast to grow by 35% in the next 2 years.
공시 • Feb 09eHealth, Inc. Announces Randall Livingston Not Stand for Re-Election to the Board of DirectorseHealth, Inc. announced that Randall Livingston will not stand for re-election to the Board of Directors and will step down when his current term expires at the Company’s 2023 annual meeting of shareholders.
공시 • Feb 07eHealth, Inc. Welcomes Back Lara Sasken as Senior Vice President, CommunicationseHealth, Inc. announced the return of Lara Sasken as Senior Vice President of Communications. Prior to that,Lara held senior communications leadership roles at SurveyMonkey, Facebook, and GoPro.
공시 • Jan 31eHealth, Inc. to Report Q4, 2022 Results on Feb 28, 2023eHealth, Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 28, 2023
공시 • Jan 25+ 1 more updateeHealth, Inc. Provides Earning Guidance for Year Ended December 31, 2022eHealth, Inc. provided earning guidance for year ended December 31, 2022. For year ended December 31, 2022, revenue is expected to be in the range of $395 to $405 million as compared to the company’s guidance of $375 to $395 million and GAAP net loss is expected to be in the range of $93 to $88 million as compared to the company’s guidance of $115 to $92 million.
공시 • Jan 24eHealth, Inc. Appoints Ketan Babaria as SVP and Chief Digital OfficereHealth, Inc. announced the appointment of Ketan Babaria as SVP, Chief Digital Officer. Mr. Babaria joins eHealth from M1 Finance where he served as Chief Product Officer, responsible for defining the company's product vision, strategy, and roadmap to drive growth and profitability. Prior to M1 Finance, Mr. Babaria served as Chief Product Officer at Roofstock, Head of Product at LifeLock, and Sr. Director and Head of Product, D3 Incubation Unit at Capital One.
Recent Insider Transactions • Nov 26CEO & Director recently bought €240k worth of stockOn the 22nd of November, Francis Soistman bought around 80k shares on-market at roughly €3.00 per share. This transaction amounted to 23% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Francis' only on-market trade for the last 12 months.
Board Change • Nov 16High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Nov 15+ 1 more updateeHealth, Inc. Announces Management ChangesEffective November 14, 2022, John J. Stelben will join eHealth, Inc. (the “Company”) as its new senior vice president of the Company. Mr. Stelben will succeed Christine Janofsky as the Company’s senior vice president. On November 8, 2022, Ms. Janofsky's employment with the Company was terminated effective November 11, 2022. Mr. Stelben, age 61, most recently served as CFO CVS Integration for Aetna from 2017 to 2018. Prior to that, Mr. Stelben served in a number of positions of increasing responsibility at Aetna, including CFO Government Programs, which included Medicare, Medicaid and public exchange businesses, from 2013 to 2017. Mr. Stelben also served in various senior leadership roles at Coventry Health Care, Inc, for over 18 years. Mr. Stelben is a certified public accountant (inactive) and holds a B.S. degree in accounting from Fairfield University.
Reported Earnings • Nov 09Third quarter 2022 earnings released: US$1.72 loss per share (vs US$2.24 loss in 3Q 2021)Third quarter 2022 results: US$1.72 loss per share (improved from US$2.24 loss in 3Q 2021). Revenue: US$53.4m (down 17% from 3Q 2021). Net loss: US$47.0m (loss narrowed 22% from 3Q 2021). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.
공시 • Nov 08+ 1 more updateeHealth, Inc. Announces Impairment Charges for the Third Quarter Ended September 30, 2022eHealth, Inc. announced impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported Impairment charges of $3,734,000.
공시 • Oct 25eHealth, Inc. to Report Q3, 2022 Results on Nov 07, 2022eHealth, Inc. announced that they will report Q3, 2022 results on Nov 07, 2022
공시 • Oct 11eHealth, Inc. Appoints Jana Brown as Senior Vice President and Chief People OfficereHealth, Inc. announced the appointment of Jana Brown as SVP, Chief People Officer. Ms. Brown joins eHealth from Centurion Health, an independent subsidiary of Centene, where she served as EVP and Chief Human Resource Officer, responsible for human capital strategy including Talent Acquisition, Talent Management, Employee Relations, Diversity, Equity & Inclusion, Learning & Development, HR Operations, and Total Rewards. Prior to Centurion Health, she served as Head of Talent and Total Rewards at CareSource HealthPlan. She also served as SVP, HR Chief Operating Officer, and Business Partner at TIAA.
공시 • Sep 09eHealth Appoints Michelle Barbeau Chief Marketing OfficereHealth, Inc. announced the appointment of Michelle Barbeau as Chief Marketing Officer. Ms. Barbeau is a proven leader with a wealth of experience in the healthcare industry. She comes to eHealth from Ableto, a provider of virtual mental health services, where she led their marketing and communications strategy with a focus on designing experiences that drive loyalty and high ROI. Prior to this, she served four years as a Vice President at UnitedHealthcare, where she transformed a team focused on employer and individual member engagement. She also served eight years in marketing management roles at General Mills.
공시 • Aug 09+ 1 more updateeHealth, Inc. Announces Departure of Phillip Morelock as Chief Digital OfficerOn August 3, 2022, Phillip Morelock’s employment as Chief Digital Officer of eHealth, Inc. ceased and he departed the Company.
Reported Earnings • Aug 09Second quarter 2022 earnings released: US$1.65 loss per share (vs US$0.86 loss in 2Q 2021)Second quarter 2022 results: US$1.65 loss per share (down from US$0.86 loss in 2Q 2021). Revenue: US$50.4m (down 48% from 2Q 2021). Net loss: US$45.0m (loss widened 97% from 2Q 2021). Over the next year, revenue is forecast to grow 3.5%, compared to a 26% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.
공시 • Jul 28eHealth, Inc. to Report Q2, 2022 Results on Aug 08, 2022eHealth, Inc. announced that they will report Q2, 2022 results on Aug 08, 2022
공시 • Jun 30eHealth, Inc. Appoints Gavin Galimi as Senior Vice President, General Counsel and Corporate SecretaryeHealth, Inc. announced the appointment of Gavin Galimi as Senior Vice President, General Counsel and Corporate Secretary. Mr. Galimi comes to eHealth with a wealth of experience in the health insurance sector, including 15 years at UnitedHealth Group. He most recently served as General Counsel for UnitedHealthcare Specialty Benefits. In 2017, he co-founded Stratagem Investments, a private equity firm focused on solving society's inequities and disparities in access to good care. He earned his JD at the University of Southern California and his BS in Biological Sciences and BA in International Relations, each from USC.
공시 • Jun 04eHealth, Inc. Announces Management ChangesOn May 31, 2022, eHealth, Inc. appointed John Dolan as chief accounting officer and principal accounting officer of the Company, effective May 31, 2022. Mr. Dolan assumes responsibility as principal accounting officer from Christine Janofsky, who will continue her role as the Company’s chief financial officer and principal financial officer. Mr. Dolan, 54, previously served as deputy controller of The Bank of New York Mellon Corporation, from March 2017 to May 2022. Mr. Dolan also held various senior positions at American Express Company from 2004 to 2017, including most recently as vice president, Americas and global accounting policies controller. Mr. Dolan is a certified public accountant and holds a B.S in accounting from Manhattan College.
Reported Earnings • May 04First quarter 2022 earnings released: US$1.28 loss per share (vs US$0.03 loss in 1Q 2021)First quarter 2022 results: US$1.28 loss per share (down from US$0.03 loss in 1Q 2021). Revenue: US$105.3m (down 22% from 1Q 2021). Net loss: US$35.0m (loss widened US$34.2m from 1Q 2021). Over the next year, revenue is expected to shrink by 7.6% compared to a 20% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance.
공시 • May 03eHealth, Inc., Annual General Meeting, Jun 15, 2022eHealth, Inc., Annual General Meeting, Jun 15, 2022, at 08:30 Pacific Standard Time. Agenda: To elect the three Class I director nominees to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal; to ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2022; to vote to approve, on an advisory basis, the compensation of Named Executive Officers; to vote to approve an amendment to our Amended and Restated 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares; and to transact such other business as may properly come before the Annual Meeting or at any postponement or adjournment of the Annual Meeting.
Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Independent Director Randy Livingston is the most experienced director on the board, commencing their role in 2008. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Apr 21eHealth, Inc. to Report Q1, 2022 Results on May 03, 2022eHealth, Inc. announced that they will report Q1, 2022 results on May 03, 2022
Recent Insider Transactions • Mar 21Independent Chairman of the Board recently bought €187k worth of stockOn the 14th of March, Dale Wolf bought around 20k shares on-market at roughly €9.36 per share. This was the largest purchase by an insider in the last 3 months. Dale has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares.
Recent Insider Transactions • Mar 08Chief Digital Officer recently sold €75k worth of stockOn the 4th of March, Phillip Morelock sold around 7k shares on-market at roughly €10.77 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought €2.3m more than they sold in the last 12 months.
공시 • Mar 04Ehealth, Inc. Corrects Earnings Guidance for the Full Year Ending December 31, 2022eHealth, Inc. corrected earnings guidance for the full year ending December 31, 2022. The guidance for GAAP net loss for the full year ending December 31, 2022 in the section titled “2022 Guidance” of the March 1, 2022 press release is corrected as set forth below: --GAAP net loss for the full year ending December 31, 2022 is expected to be in the range of $106.0 million to $83.0 million, corrected from a range of $147.0 million to $124.0 million. Total revenue is expected to be in the range of $448.0 million to $470.0 million.
공시 • Mar 03eHealth, Inc. Provides Earnings Guidance for the Full year Ending December 31, 2022eHealth, Inc. provided earnings guidance for the full year ending December 31, 2022. The company expects total revenue to be in the range of $448.0 million to $470.0 million and GAAP net loss is expected to be in the range of $147.0 million to $124.0 million.